Practice and Advocacy
AAO-HNS StorePQRI Measures
How to Choose Measures:
- Please choose at least three measures for the conditions that you see and the procedures that you perform the most.
- Please choose those measures that apply to patients aged 65 and older (including those with age ranges that include 65 such as 18 and older or 2 years and older) for the Medicare PQRI program.
- Please choose measures that do not apply to those aged 65 and older for in office quality improvement efforts or incentive programs with plans/payers other than Medicare.
Measure #4: Screening for Future Fall Risk
DESCRIPTION:
Percentage of patients aged 65 years and older who were screened for future fall risk (patients are considered at risk for future falls if they have had 2 or more falls in the past year or any fall with injury in the past year) at least once within 12 months
Measure #4 Full Specifications
Measure #20: Perioperative Care: Timing of Antibiotic Prophylaxis – Ordering Physician
DESCRIPTION:
Percentage of surgical patients aged 18 years and older undergoing procedures with the indications for prophylactic parenteral antibiotics, who have an order for prophylactic antibiotic to be given within one hour (if fluoroquinolone or vancomycin, two hours), prior to the surgical incision (or start of procedure when no incision is required)
Measure #20 Full Specifications
Measure #21: Perioperative Care: Selection of Prophylactic Antibiotic – First OR Second Generation Cephalosporin
DESCRIPTION:
Percentage of surgical patients aged 18 years and older undergoing procedures with the indications for a first OR second generation cephalosporin prophylactic antibiotic, who had an order for cefazolin OR cefuroxime for antimicrobial prophylaxis
Measure #21 Full Specifications
Measure #22: Perioperative Care: Discontinuation of Prophylactic Antibiotics (Non-Cardiac Procedures)
DESCRIPTION:
Percentage of non-cardiac surgical patients aged 18 years and older undergoing procedures with the indications for prophylactic antibiotics AND who received a prophylactic antibiotic, who have an order for discontinuation of prophylactic antibiotics within 24 hours of surgical end time
Measure #22 Full Specifications
Measure #23: Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients)
DESCRIPTION:
Percentage of patients aged 18 years and older undergoing procedures for which VTE prophylaxis is indicated in all patients, who had an order for Low Molecular Weight Heparin (LMWH), Low-Dose Unfractionated Heparin (LDUH), adjusted-dose warfarin, fondaparinux or mechanical prophylaxis to be given within 24 hours prior to incision time or within 24 hours after surgery end time
Measure #23 Full Specifications
Measure #46: Medication Reconciliation
DESCRIPTION:
Percentage of patients aged 65 years and older discharged from any inpatient facility (e.g., hospital, skilled nursing facility, or rehabilitation facility) and seen within 60 days following discharge in the office by the physician providing on-going care who had a reconciliation of the discharge medications with the current medication list in the medical record documented
Measure #46 Full Specifications
Measure #53: Asthma: Pharmacologic Therapy
DESCRIPTION:
Percentage of patients aged 5 through 40 years with a diagnosis of mild, moderate, or severe persistent asthma who were prescribed either the preferred long-term control medication (inhaled corticosteroid) or an acceptable alternative treatment
Measure #53 Full Specifications
Measure #64: Asthma Assessment
DESCRIPTION:
Percentage of patients aged 5 through 40 years with a diagnosis of asthma who were evaluated during at least one office visit within 12 months for the frequency (numeric) of daytime and nocturnal asthma symptoms
Measure #64 Full Specifications
Measure #65: Appropriate Treatment for Children with Upper Respiratory Infection (URI)
DESCRIPTION:
Percentage of children aged 3 months through 18 years with a diagnosis of upper respiratory infection (URI) who were not prescribed or dispensed an antibiotic prescription on or within 3 days of the initial date of service
Measure #65 Full Specifications
Measure #66: Appropriate Testing for Children with Pharyngitis
DESCRIPTION:
Percentage of children aged 2 through 18 years with a diagnosis of pharyngitis, who were prescribed an antibiotic and who received a group A streptococcus (strep) test for the episode
Measure #66 Full Specifications
Measure #77: Assessment of GERD Symptoms in Patients Receiving Chronic Medication for GERD
DESCRIPTION:
Percentage of patients aged 18 years and older with the diagnosis of gastroesophageal reflux disease (GERD) who have been prescribed continuous proton pump inhibitor (PPI) or histamine H2 receptor antagonist (H2RA) therapy who received an annual assessment of their GERD symptoms after 12 months of therapy
Measure #77 Full Specifications
Measure #91: Acute Otitis Externa (AOE): Topical Therapy
DESCRIPTION:
Percentage of patients aged 2 years and older with a diagnosis of AOE who were prescribed topical preparations
Measure #91 Full Specifications
Measure #92: Acute Otitis Externa (AOE): Pain Assessment
DESCRIPTION:
Percentage of patient visits for those patients aged 2 years and older with a diagnosis of AOE with assessment for auricular or periauricular pain
Measure #92 Full Specifications
Measure #93: Acute Otitis Externa (AOE): Systemic Antimicrobial Therapy – Avoidance of Inappropriate Use
DESCRIPTION:
Percentage of patients aged 2 years and older with a diagnosis of AOE who were not prescribed systemic antimicrobial therapy
Measure #93 Full Specifications
#94 Otitis Media with Effusion (OME): Diagnostic Evaluation – Assessment of Tympanic Membrane Mobility (does NOT apply to patients 65 and older)
DESCRIPTION:
Percentage of patient visits for those patients aged 2 months through 12 years with a diagnosis of OME with assessment of tympanic membrane mobility with pneumatic otoscopy or tympanometry.
Measure #94 Full Specifications
Measure #94 Summary Table
#95 Otitis Media with Effusion (OME): Hearing Testing (does NOT apply to patients 65 and older)
DESCRIPTION:
Percentage of patients aged 2 months through 12 years with a diagnosis of OME who received tympanostomy tube insertion who had a hearing test performed within 6 months prior to tympanostomy tube insertion.
Measure #95 Full Specifications
Measure #95 Summary Table
#96 Otitis Media with Effusion (OME): Antihistamines or Decongestants – Avoidance of Inappropriate Use (does NOT apply to patients 65 and older)
DESCRIPTION:
Percentage of patients aged 2 months through 12 years with a diagnosis of OME who were not prescribed/recommended either antihistamines or decongestants.
Measure #96 Full Specifications
Measure #96 Summary Table
#97 Otitis Media with Effusion (OME): Systemic Antimicrobials – Avoidance of Inappropriate Use (does NOT apply to patients 65 and older)
DESCRIPTION:
Percentage of patients aged 2 months through 12 years with a diagnosis of OME who were not prescribed systemic antimicrobials.
Measure #97 Full Specifications
Measure #97 Summary Table
#98 Otitis Media with Effusion (OME): Systemic Corticosteroids – Avoidance of Inappropriate Use (does NOT apply to patients 65 and older)
DESCRIPTION:
Percentage of patients aged 2 months through 12 years with a diagnosis of OME who were not prescribed systemic corticosteroids.
Measure #98 Full Specifications
Measure #98 Summary Table
Measure #110: Influenza Vaccination for Patients ≥ 50 Years Old
DESCRIPTION:
Percentage of patients aged 50 years and older who received an influenza immunization during the flu season (September through February)
Measure #110 Full Specifications
Measure #111: Pneumonia Vaccination for Patients 65 Years and Older
DESCRIPTION:
Percentage of patients aged 65 years and older who have ever received a pneumococcal vaccine
Measure #111 Full Specifications
Measure #124: HIT - Adoption/Use of Health Information Technology (Electronic Health Records)
DESCRIPTION:
Documents whether provider has adopted and is using health information technology. To qualify, the provider must have adopted a qualified electronic medical record (EMR). For the purpose of this measure, a qualified EMR can either be a Certification Commission for Healthcare Information Technology (CCHIT) certified EMR or, if not CCHIT certified, the system must be capable of all of the following:
- Generating a medication list
- Generating a problem list
- Entering laboratory tests as discrete searchable data elements
Measure #124 Full Specifications
Measure #124 Summary Table
Measure #125: HIT - Adoption/Use of e-Prescribing
DESCRIPTION:
Documents whether provider has adopted a qualified e-Prescribing system and the extent of use in the ambulatory setting. To qualify this system must be capable of ALL of the following:
Generating a complete active medication list incorporating electronic data received from applicable pharmacy drug plan(s) if available
Selecting medications, printing prescriptions, electronically transmitting prescriptions, and conducting all safety checks (defined below)
Providing information related to the availability of lower cost, therapeutically appropriate alternatives (if any)
Providing information on formulary or tiered formulary medications, patient eligibility, and authorization requirements received electronically from the patient’s drug plan
Find an ENT
Practice Management Workshops
Workshops held in cities nationwide will help otolaryngologists, their staff, and other healthcare professionals code correctly, learn risk reduction strategies, and organize business systems.
